The word exosome used to belong to cell biology papers. Now it appears on serum bottles, in clinic menus and in celebrity skincare routines. The rise has been fast enough that regulation, research and marketing are moving at three different speeds.
If you are considering an exosome treatment, it helps to separate those three.
What an exosome is
Cells release tiny packages called extracellular vesicles. Exosomes are one type. They carry proteins, lipids, growth factors and genetic material from one cell to another, and scientists study them because they appear to play a role in how tissue signals for repair.
The idea behind using them on skin follows from that. If you can deliver signalling molecules that encourage collagen production and calm inflammation, you might speed healing after a laser or improve skin quality over time.
How that differs from PRP
Platelet-rich plasma came first. A clinician draws your blood, spins it in a centrifuge to concentrate the platelets, and applies or injects the result. Platelets release growth factors that support collagen and elastin production. Dermatologists and plastic surgeons have used PRP with microneedling for years, and the evidence base for PRP is broader than for exosomes.
Exosomes are one step further down the chain. Rather than using whole platelets, a treatment uses the vesicles themselves.
The source matters. Many commercial exosome products derive from donor cells. Some clinics take a different route. FACES+ in San Diego offers ExoCube, a device the practice says converts a patient’s own PRP into autologous exosomes for topical use or injection. Using your own blood removes the question of donor material, although it does not answer every question about dose and consistency.
Where the FDA stands
The US Food and Drug Administration has not approved any exosome product for cosmetic or therapeutic use. The agency has issued public safety notifications warning consumers about clinics marketing unapproved stem cell and exosome products, including products injected to treat disease.
That does not make every aesthetic use unlawful or unsafe. It does mean that claims on a clinic website have not been through FDA review. As a patient, you carry more of the burden of asking questions.
What the research shows so far
Laboratory and early clinical studies suggest exosomes may support wound healing and reduce redness after resurfacing procedures. Many studies are small, use different preparations, and measure different outcomes, which makes comparison hard. Large randomized trials on aesthetic outcomes remain scarce.
A fair summary: the biology is plausible, early results are encouraging, and the evidence is not yet strong enough to promise a specific result.
How surgeons are using them now
Careful clinicians tend to use exosomes as a supporting act rather than the main treatment. At FACES+, Dr. Steven R. Cohen applies exosome serums after non-surgical procedures such as Fraxel laser, microneedling and Ellacor, aiming to support collagen growth and reduce inflammation during recovery. He also co-developed Morphiya, an exosome-based skincare line.
Cohen’s interest comes from a long background in regenerative medicine. He serves as section editor for fat grafting and stem cells at the Aesthetic Surgery Journal and co-created Lipocube, a device for processing fat to concentrate regenerative cells.
Questions to ask before you pay
- Where do the exosomes come from: my own blood, or donor cells?
- What is the product, who makes it, and what testing does it undergo?
- Is this applied to the skin or injected?
- What result should I expect, and what published evidence supports that expectation?
- What does it add to the procedure I am already having?
A clinic that answers those in plain terms, and tells you what remains unknown, is treating exosomes the way today’s evidence justifies.
